Matches in SemOpenAlex for { <https://semopenalex.org/work/W2072604295> ?p ?o ?g. }
Showing items 1 to 100 of
100
with 100 items per page.
- W2072604295 endingPage "1341" @default.
- W2072604295 startingPage "1335" @default.
- W2072604295 abstract "Article AbstractBackground: This randomized, double-blind, placebo-controlled trial was designed to assess the efficacy and safety of topiramate in bulimia nervosa. Method: Patients with DSM-IV bulimia nervosa were randomly assigned in equal proportions to receive topiramate (N = 35) or placebo (N = 34) for 10 weeks (between April 1999 and Dec. 2000). Topiramate treatment was started at 25 mg/day and titrated by 25 to 50 mg/week to a maximum of 400 mg/day. The primary efficacy measure was mean weekly number of binge and/or purge days. Related outcome measures included mean weekly number of binge days and binge frequency, as well as mean weekly number of purge days and purge frequency. Results: Sixty-four outpatients (33 placebo, 31 topiramate) were included in the intent-to-treat analysis. The median topiramate dose was 100 mg/day (range, 25-400 mg/day). Mean ± SD baseline number of weekly binge and/or purge days was 5.0 ± 1.6 for topiramate patients and 5.1 ± 1.5 for placebo patients. The primary efficacy measure, mean weekly number of binge and/or purge days, decreased 44.8% from baseline with topiramate versus 10.7% with placebo (p = .004). The mean weekly number of binge days decreased 48.2% with topiramate versus 17.7% with placebo (p = .015), and mean binge frequency decreased 49.2% with topiramate versus 28.0% with placebo (p = .071). The mean weekly number of purge days decreased 43.4% with topiramate versus 16.6% with placebo (p = .016), and mean purge frequency decreased 49.8% with topiramate versus 21.6% with placebo (p = .016). Three patients (2 placebo, 1 topiramate) discontinued from the trial due to adverse events. Conclusion: Topiramate was associated with significant improvements in both binge and purge symptoms in this study population and represents a potential treatment for bulimia nervosa." @default.
- W2072604295 created "2016-06-24" @default.
- W2072604295 creator A5015806815 @default.
- W2072604295 creator A5020463312 @default.
- W2072604295 creator A5033661505 @default.
- W2072604295 creator A5040865067 @default.
- W2072604295 creator A5064921523 @default.
- W2072604295 creator A5069971026 @default.
- W2072604295 creator A5074233460 @default.
- W2072604295 creator A5079035624 @default.
- W2072604295 date "2003-11-15" @default.
- W2072604295 modified "2023-10-02" @default.
- W2072604295 title "Treatment of Bulimia Nervosa With Topiramate in a Randomized, Double-Blind, Placebo-Controlled Trial, Part 1" @default.
- W2072604295 doi "https://doi.org/10.4088/jcp.v64n1109" @default.
- W2072604295 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14728106" @default.
- W2072604295 hasPublicationYear "2003" @default.
- W2072604295 type Work @default.
- W2072604295 sameAs 2072604295 @default.
- W2072604295 citedByCount "159" @default.
- W2072604295 countsByYear W20726042952012 @default.
- W2072604295 countsByYear W20726042952013 @default.
- W2072604295 countsByYear W20726042952014 @default.
- W2072604295 countsByYear W20726042952015 @default.
- W2072604295 countsByYear W20726042952016 @default.
- W2072604295 countsByYear W20726042952017 @default.
- W2072604295 countsByYear W20726042952018 @default.
- W2072604295 countsByYear W20726042952019 @default.
- W2072604295 countsByYear W20726042952020 @default.
- W2072604295 countsByYear W20726042952021 @default.
- W2072604295 countsByYear W20726042952022 @default.
- W2072604295 countsByYear W20726042952023 @default.
- W2072604295 crossrefType "journal-article" @default.
- W2072604295 hasAuthorship W2072604295A5015806815 @default.
- W2072604295 hasAuthorship W2072604295A5020463312 @default.
- W2072604295 hasAuthorship W2072604295A5033661505 @default.
- W2072604295 hasAuthorship W2072604295A5040865067 @default.
- W2072604295 hasAuthorship W2072604295A5064921523 @default.
- W2072604295 hasAuthorship W2072604295A5069971026 @default.
- W2072604295 hasAuthorship W2072604295A5074233460 @default.
- W2072604295 hasAuthorship W2072604295A5079035624 @default.
- W2072604295 hasConcept C118552586 @default.
- W2072604295 hasConcept C126322002 @default.
- W2072604295 hasConcept C142724271 @default.
- W2072604295 hasConcept C15744967 @default.
- W2072604295 hasConcept C168563851 @default.
- W2072604295 hasConcept C17744445 @default.
- W2072604295 hasConcept C199539241 @default.
- W2072604295 hasConcept C204243189 @default.
- W2072604295 hasConcept C204787440 @default.
- W2072604295 hasConcept C27081682 @default.
- W2072604295 hasConcept C2776394216 @default.
- W2072604295 hasConcept C2776722196 @default.
- W2072604295 hasConcept C2777556793 @default.
- W2072604295 hasConcept C2777683783 @default.
- W2072604295 hasConcept C2778186239 @default.
- W2072604295 hasConcept C2781426410 @default.
- W2072604295 hasConcept C42219234 @default.
- W2072604295 hasConcept C511355011 @default.
- W2072604295 hasConcept C71924100 @default.
- W2072604295 hasConceptScore W2072604295C118552586 @default.
- W2072604295 hasConceptScore W2072604295C126322002 @default.
- W2072604295 hasConceptScore W2072604295C142724271 @default.
- W2072604295 hasConceptScore W2072604295C15744967 @default.
- W2072604295 hasConceptScore W2072604295C168563851 @default.
- W2072604295 hasConceptScore W2072604295C17744445 @default.
- W2072604295 hasConceptScore W2072604295C199539241 @default.
- W2072604295 hasConceptScore W2072604295C204243189 @default.
- W2072604295 hasConceptScore W2072604295C204787440 @default.
- W2072604295 hasConceptScore W2072604295C27081682 @default.
- W2072604295 hasConceptScore W2072604295C2776394216 @default.
- W2072604295 hasConceptScore W2072604295C2776722196 @default.
- W2072604295 hasConceptScore W2072604295C2777556793 @default.
- W2072604295 hasConceptScore W2072604295C2777683783 @default.
- W2072604295 hasConceptScore W2072604295C2778186239 @default.
- W2072604295 hasConceptScore W2072604295C2781426410 @default.
- W2072604295 hasConceptScore W2072604295C42219234 @default.
- W2072604295 hasConceptScore W2072604295C511355011 @default.
- W2072604295 hasConceptScore W2072604295C71924100 @default.
- W2072604295 hasIssue "11" @default.
- W2072604295 hasLocation W20726042951 @default.
- W2072604295 hasLocation W20726042952 @default.
- W2072604295 hasOpenAccess W2072604295 @default.
- W2072604295 hasPrimaryLocation W20726042951 @default.
- W2072604295 hasRelatedWork W1964245944 @default.
- W2072604295 hasRelatedWork W1978267780 @default.
- W2072604295 hasRelatedWork W1981642546 @default.
- W2072604295 hasRelatedWork W2053295481 @default.
- W2072604295 hasRelatedWork W2071280461 @default.
- W2072604295 hasRelatedWork W2072604295 @default.
- W2072604295 hasRelatedWork W2103264791 @default.
- W2072604295 hasRelatedWork W2157829642 @default.
- W2072604295 hasRelatedWork W2489742698 @default.
- W2072604295 hasRelatedWork W4233643609 @default.
- W2072604295 hasVolume "64" @default.
- W2072604295 isParatext "false" @default.
- W2072604295 isRetracted "false" @default.
- W2072604295 magId "2072604295" @default.
- W2072604295 workType "article" @default.